CO5170461A1 - Derivados de 1,5-benzodiazepina mente, composicion farmaceutica que lo contiene, proceso pa- ra su preparacion y proceso mejorado para la preparacion de los intermediarios para la sisntesis de dicho derivado - Google Patents

Derivados de 1,5-benzodiazepina mente, composicion farmaceutica que lo contiene, proceso pa- ra su preparacion y proceso mejorado para la preparacion de los intermediarios para la sisntesis de dicho derivado

Info

Publication number
CO5170461A1
CO5170461A1 CO00031982A CO00031982A CO5170461A1 CO 5170461 A1 CO5170461 A1 CO 5170461A1 CO 00031982 A CO00031982 A CO 00031982A CO 00031982 A CO00031982 A CO 00031982A CO 5170461 A1 CO5170461 A1 CO 5170461A1
Authority
CO
Colombia
Prior art keywords
preparation
phenyl
formula
mfi
jpeg
Prior art date
Application number
CO00031982A
Other languages
English (en)
Spanish (es)
Inventor
David Colclough
Ann Hodgson
Szewczyk Jerzy Ryszard
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO5170461A1 publication Critical patent/CO5170461A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00031982A 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina mente, composicion farmaceutica que lo contiene, proceso pa- ra su preparacion y proceso mejorado para la preparacion de los intermediarios para la sisntesis de dicho derivado CO5170461A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process

Publications (1)

Publication Number Publication Date
CO5170461A1 true CO5170461A1 (es) 2002-06-27

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00031982A CO5170461A1 (es) 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina mente, composicion farmaceutica que lo contiene, proceso pa- ra su preparacion y proceso mejorado para la preparacion de los intermediarios para la sisntesis de dicho derivado

Country Status (21)

Country Link
EP (1) EP1212305A2 (zh)
JP (1) JP2002544200A (zh)
KR (1) KR20020012567A (zh)
CN (1) CN1161345C (zh)
AR (1) AR022044A1 (zh)
AU (1) AU4754800A (zh)
BR (1) BR0010338A (zh)
CA (1) CA2370801A1 (zh)
CO (1) CO5170461A1 (zh)
CZ (1) CZ20013988A3 (zh)
HK (1) HK1046138A1 (zh)
HU (1) HUP0201181A3 (zh)
IL (1) IL146124A0 (zh)
MX (1) MXPA01011267A (zh)
MY (1) MY138319A (zh)
NO (1) NO20015397L (zh)
NZ (1) NZ515048A (zh)
PE (1) PE20010110A1 (zh)
PL (1) PL351546A1 (zh)
TR (1) TR200103169T2 (zh)
WO (1) WO2000068209A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
JP4069159B2 (ja) 2004-05-25 2008-04-02 ファイザー・プロダクツ・インク テトラアザベンゾ［ｅ］アズレン誘導体及びそれらのアナログ
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
NZ515048A (en) 2004-01-30
TR200103169T2 (tr) 2002-04-22
AU4754800A (en) 2000-11-21
CN1161345C (zh) 2004-08-11
IL146124A0 (en) 2002-07-25
NO20015397D0 (no) 2001-11-05
WO2000068209A2 (en) 2000-11-16
KR20020012567A (ko) 2002-02-16
MY138319A (en) 2009-05-29
CN1362949A (zh) 2002-08-07
EP1212305A2 (en) 2002-06-12
MXPA01011267A (es) 2002-05-06
JP2002544200A (ja) 2002-12-24
HUP0201181A3 (en) 2003-10-28
BR0010338A (pt) 2002-02-13
CA2370801A1 (en) 2000-11-16
PL351546A1 (en) 2003-05-05
CZ20013988A3 (cs) 2002-02-13
NO20015397L (no) 2001-11-05
HK1046138A1 (zh) 2002-12-27
PE20010110A1 (es) 2001-03-05
AR022044A1 (es) 2002-09-04
WO2000068209A3 (en) 2001-03-01
HUP0201181A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
ES545885A0 (es) Un metodo para preparar 4-(4-(dimetilamino)-1-(4'-fluoro- fenil)-1-hidroxibutil)-3-(hidroximetil)-benzonitrilo
AU6116698A (en) Amine compounds, their production and use as amyloid-beta production inhibitors
CO5690131A1 (es) Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento de transtornos del snc
KR910006277A (ko) N-치환된-4-피리미딘아민 및 피리미딘디아민, 이의 제조방법 및 약제로서의 이의 용도
GEP19970661B (en) Process for preparing arylcyclobutyl alkylamine derivatives
BR9812944A (pt) Inibidores bicìclicos da cinase
CO5070574A1 (es) Derivado del acido fenoxiacetico y composicion farmaceutica que lo contiene
PT83202B (pt) Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem
MY129649A (en) Chiral salt resolution
BR0310077A (pt) Novos compostos e sua utilização
CO5420196A1 (es) Compuestos inhibidores de metaloproteasa bidentes, composi- ciones farmaceuticas que los contienne y metodos para su utilizacion
ATE236123T1 (de) Thermodynamisch stabile modifizierung von 1-(4- carbazolyloxy)-3- (2-(2- methoxyphenoxy)ethylamino)-2-propanol, verfahren zu ihrer herstellung und ihre enthaltende pharmazeutische zusammensetzungen
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
KR900004658A (ko) 이치환 벤질아민, 그의 제조방법, 약제로서의 그의 용도 및 그의 합성 약제
CO5261594A1 (es) Inhibidores de myt1 cinasa
CO5170461A1 (es) Derivados de 1,5-benzodiazepina mente, composicion farmaceutica que lo contiene, proceso pa- ra su preparacion y proceso mejorado para la preparacion de los intermediarios para la sisntesis de dicho derivado
ES2216333T3 (es) Derivados de isoquinolina sustituida y su uso como anticonvulsivos.
NO973213L (no) Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse
PT1234818E (pt) Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem
BR9406897A (pt) Compostos de tetraidroisoquinolina composiçoes farmaceuticas processo de analgesia ou de tratamento de psicoses doença de parkinson sindrome de leschnyan distúrbio da falta de atençao ou danos cognitivos ou na supressao da dependencia de drogas ou discinesia tardia e uso de um composto
SE9103022D0 (sv) Nya 5h-bensodiazepinderivat, farmaceutiska kompositioner innehaallande desamma samt foerfarande foer framstaellning av dessa
DE60038112T8 (de) Verfahren zur herstellung von (1r, 2s, 4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptan und ihre pharmazeutisch akzeptierbaren säure-additions-salze
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
AR026222A1 (es) Compuestos derivados de acido antranilico
AR002772A1 (es) Procedimiento para separar un racemato de (+--)-(2r,3r;2s,3s)-1-azabiciclo-[2.2.2] octan-3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metil-etil)fenil]metilo], y procedimiento para prepoarar un enantiomero (2s,3s) de 1-azabiciclo-[2,.2.2] octan-3-amina, 2-(difenil-metil)-n-[[2-metoxi-5-(1-metil-etil)-fenil]metilo]

Legal Events

Date Code Title Description
FC Application refused